Found 20 matches for
Monday 1st July 2013 saw the official launch of OCTRU. 2 years on, OCTRU has exceeded expectations and has a growing portfolio of trials. It now has 37 funded trials on its register which should result in 11,623 randomisations when all are complete.
Botnar Inflammation biology Orthopaedics and trauma Tissue remodelling and regeneration
The Dakin Group undertakes translational research focusing on identifying the cellular basis of inflammatory fibrotic musculoskeletal diseases, with research programmes on tendinopathy and frozen shoulder. Understanding the cellular and molecular basis of these diseases will inform new therapeutic approaches targeting tissue resident stromal cells of the joint, to promote resolution of chronic inflammation and fibrosis.